Previously, we reported the successful correction of the causative mutation in the rd12 mouse model of Leber congenital amaurosis (LCA) through delivery of an adenine base editor (ABE) via LV41, AAV42 and engineered virus-like particles (eVLP)28. This evidence concerns the gene RPE65 and Leber congenital amaurosis.